Heart drug dobutamine put to the test in rare amyloid heart disease
Knowledge-focused
Recruiting now
This early-stage trial is studying how the drug dobutamine affects the heart in 15 people with a rare condition called wild-type transthyretin amyloid cardiomyopathy (ATTRwt). Participants will receive increasing doses of dobutamine while doctors measure heart function using ultr…
Phase: PHASE1, PHASE2 • Sponsor: Steen Hvitfeldt Poulsen • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:01 UTC